Related Experiment Video
Updated: Aug 16, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Nuances of new anti-Aspergillus antifungals
1Duke University Medical Center, Durham, NC 27710, USA. perfe001@mc.duke.edu
Abstract:
Invasive aspergillosis (IA) is a serious complication of immunosuppression, and has become more widespread as the immunocompromised population has increased as a result of new treatment strategies and diseases. This paper identifies and discusses seven issues for managing IA and combating drug resistance. Management of IA requires a multifactorial approach with the host as a major contributor to management strategies and outcome. However, significant progress has been made, and with careful use of the clinical tools available it is possible to make a successful impact on infection outcomes.
More Related Videos
Related Concept Videos
Antifungal Agents
Affinity and Avidity
Cross-reactivity
Fungal Phylum Ascomycota
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...

